HOME
ABOUT US
SERVICES
RESEARCH
EQUITY
DERIVATIVES
IPO
INTERNET TRADING
FTP
CONTACT US
SENSEX
-445.59
-0.62%
71580.56
NIFTY
-133.60
-0.62%
21577.20
Nasdaq
13.77
0.09%
14524.07
Nikkei 225
89.13
0.27%
33377.42
FTSE 100
-33.50
-0.43%
7689.60
YOU ARE ON
Equity
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Most Active
Bulk Deals
Block Deals
Highest & Lowest Delivery
Analysis
Live Indices
Rising VDP
Rising VD & Falling Price
News Analysis
Hot Stocks
Opening Bell
Midday Review
Closing Bell
Other Market
Corporate News
Market Pulse
Economy
Company Result
FII Position
Global Markets
Current Affairs & Politics
Mutual Fund News
Market Commentry
Corporate Action
BSE Announcements
NSE Announcements
Book Closure
Board Meetings
Bonus Issues
Right Issues
Split of Face Value
Dividend Details
Delisted Companies
Change Of Name
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Share Price
MF Holdings
Price Charts
Company News
CompanyChart
Cash Flow
Share Holdings
Deliverable Volume
Historical Volume
Directors Reports
Peer Comparison
Board Meetings
Corporate Announcements
Book Closure
Bonus Issues
AGM
Other Market
FII Investments
DII Investments
World Indices
ADR Prices
Forex
Torrent Pharmaceuticals Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
09-Oct-2023
23-Oct-2023
Quarterly Results
17-Jul-2023
07-Aug-2023
Quarterly Results
16-May-2023
30-May-2023
Final Dividend & Audited Results
12-Jan-2023
25-Jan-2023
Quarterly Results & Interim Dividend
04-Oct-2022
21-Oct-2022
Quarterly Results
11-Jul-2022
29-Jul-2022
Quarterly Results
06-May-2022
25-May-2022
Final Dividend & Bonus issue & Audited Results
10-Jan-2022
25-Jan-2022
Quarterly Results & Interim Dividend
11-Oct-2021
26-Oct-2021
Quarterly Results
09-Jul-2021
27-Jul-2021
Quarterly Results
28-Apr-2021
18-May-2021
Audited Results & Final Dividend Inter alia, the Board would also consider the following: i. Payment of Final Dividend for the year 2020-21. ii. Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If approved by the Board of Directors, the said item will be placed for Shareholders' approval in the ensuing Annual General Meetin
18-Jan-2021
08-Feb-2021
Interim Dividend & Quarterly Results
13-Oct-2020
26-Oct-2020
Quarterly Results
14-Jul-2020
30-Jul-2020
Quarterly Results
18-May-2020
26-May-2020
Audited Results
03-Mar-2020
11-Mar-2020
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/03/2020 ,inter alia, to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday, 11th March, 2020 to consider the proposal for payment of Interim Dividend for the year 2019-20.
15-Jan-2020
27-Jan-2020
Interim Dividend & Quarterly Results & In the meeting, the Board would also consider the following: 1. Payment oflnterim Dividend for the year 2019-20. 2. Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If such issue of Equity shares is approved by the Board of Directors, Shareholders' approval will be taken through postal ballot.
14-Oct-2019
23-Oct-2019
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2019 ,inter alia, to consider and approve We would like to inform you that meeting of the Board of Directors will be held on Wednesday,23-0ct-19, inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-19.
10-Jul-2019
23-Jul-2019
Quarterly Results
06-May-2019
20-May-2019
Final Dividend inter alia, consider the recommendation of Final Dividend for the year ended 31-Mar-19. & Audited Results inter alia, to consider and approve the Audited Financial Results for the year ended on 31 -Mar-19.
Page
1
of
5
Prev
||
Next
KYC Standard Document Kit of MCX-SX
NSE BSE & CDSL KYC format
ADINATH PMLA
INTERNAL_CONTROL_POLICY
RISK MANAGEMENT AND SURVELLANCE POLICY
ADINATH STOCK BROKING PVT LTD :
SEBI REGISTRATION NUMBERS : Bombay Stock Exchange(BSE): CASH -INZ000204337 & DERIVATIVE -INZ000204337 Member ID-3175 National Stock Exchange(NSE): CASH- INZ000204337 & DERIVATIVES -INZ000204337 Member ID-12805 MCX-SX Stock Exchange(MCX-SX): Currency Derivative : INZ000204337 Member ID-44400 United Stock Exchange(USE): Currency Derivative: Central Depository Services Ltd(CDSL)- IN -DP-452/2008 DP ID 12055200
ADINATH COMMODITIES :
COMMODITIES SEBI REGISTRATION NUMBERS : INZ000042629 MultiCommodity Exchange Ltd (MCX):Member ID -10140 National Commodity and Derivatives Exchange Ltd (NCDEX):Member ID -00622.
ATTENTION INVESTORS :
"Prevent unauthorised transactions in your Broking & demat account--> Update your mobile numbers/email IDs with your stock brokers & depository participate. Receive information of your transactions directly from Exchange & CDSL on your mobile/email at the end of the day......................Issued in the interest of Investors"
ATTENTION INVESTORS :
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
ATTENTION INVESTORS :
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. "Issued in the interest of Investors"
|
Disclaimer
|
Privacy Policy
|
Feedback
|
Terms and Conditions
|
Careers
|
Investor Grievances
|
Download
|
Investor Protection
|
SCORES
|
Site Map
Investor Charter - DP
|
Investor Charter - Stock Broker
|
e-voting
|
Investor Education
Useful links:
NSE
|
BSE
|
MCX-SX
|
CDSL
|
SEBI
|
MCX
|
NCDEX
|
FMC
|
Smart ODR
SEBI Registration No.INZ000042629
Copyright © 2011 Adinath Stock Broking Pvt Ltd Designed, Developed & Content Powered By
●
●
●
Accord Fintech Pvt.Ltd.
CLOSE
X
Filing complaints on SCORES
Easy & quick
>
Register on SCORES portal
(https://scores.gov.in)
>
Mandatory details for filing complaints on SCORES
Name
PAN
Address
Mobile Number
E-mail ID
>
Benefits:
Effective communication
Speedy redressal of the grievances